XML 24 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY - USD ($)
$ in Millions
Total
Common stock
Capital in excess of par value
Retained earnings (accumulated deficit)
Accumulated other comprehensive loss
Treasury stock
Non-controlling interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Treasury stock, shares           21,200,000  
Beginning balance , common stock (in shares) at Dec. 31, 2021   (275,700,000)          
Beginning balance at Dec. 31, 2021 $ 21,117 $ 35 $ 19,826 $ 3,641 $ (1,423) $ (997) $ 35
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (1,868)     (1,871)     3
Other comprehensive income (loss) (775)       (775)    
Cash dividends declared (815)     (815)      
Stock options/SSARs (in shares)           100,000  
Stock options/SSARs 15   11     $ 4  
Vested restricted stock units and awards (26)   (41)     $ 15  
Vested restricted stock units and awards (in shares)           300,000  
Stock-based compensation 49   49        
Purchase of NCI (5)   1       (6)
Redeemable NCI (5)   (5)        
Dividends on non-controlling interest and other (2)           (2)
Ending balance (in shares) at Dec. 31, 2022   (275,700,000)          
Ending balance at Dec. 31, 2022 17,685 $ 35 19,841 955 (2,198) $ (978) 30
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Treasury stock, shares           20,800,000  
Net income (loss) (2,563)     (2,567)     4
Other comprehensive income (loss) 302       302    
Cash dividends declared (827)     (827)      
Stock options/SSARs (in shares)           100,000  
Stock options/SSARs 0   (4)     $ 4  
Vested restricted stock units and awards (11)   (22)     $ 11  
Vested restricted stock units and awards (in shares)           300,000  
Stock-based compensation 65   65        
Redeemable NCI (6)   (6)        
Dividends on non-controlling interest and other (3)           (3)
Ending balance (in shares) at Dec. 31, 2023   (275,700,000)          
Ending balance at Dec. 31, 2023 $ 14,642 $ 35 19,874 (2,439) (1,896) $ (963) 31
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Treasury stock, shares 20,400,000         20,400,000  
Net income (loss) $ 247     243     4
Other comprehensive income (loss) (631)       (631)    
Cash dividends declared (409)     (409)      
Stock options/SSARs (in shares)           0  
Stock options/SSARs 1   (1)     $ 2  
Vested restricted stock units and awards (16)   (33)     $ 17  
Vested restricted stock units and awards (in shares)           400,000  
Stock-based compensation 77   77        
Ending balance (in shares) at Dec. 31, 2024   (275,700,000)          
Ending balance at Dec. 31, 2024 $ 13,911 $ 35 $ 19,917 $ (2,605) $ (2,527) $ (944) $ 35
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Treasury stock, shares 20,000,000.0         20,000,000.0